|
【结 构 式】 
|
【分子编号】15285 【品名】6-chloro-N(4)-methyl-4,5-pyrimidinediamine; N-(5-amino-6-chloro-4-pyrimidinyl)-N-methylamine 【CA登记号】 |
【 分 子 式 】C5H7ClN4 【 分 子 量 】158.59024 【元素组成】C 37.87% H 4.45% Cl 22.35% N 35.33% |
与该中间体有关的原料药合成路线共 1 条
合成路线1
该中间体在本合成路线中的序号：(III)The overall synthetic approach to N-0861 is described in Scheme 17807901a: Reduction of 4,6-dichloro-5-nitropyrimidine (I) followed by reaction with methylamine gives 5-amino-6-chloro-4-methylaminopyrimidine (III). Cyclization with triethylorthoformate under acidic conditions results in 9-methyl-6-chloropurine (IV). Reaction of (±)-endo-2-aminonorbornane (V) with 9-methyl-6-chloropurine (IV) provides N-0861.
| 【1】 van Galen, P.; Williams, M.; Jacobson, K.; Adenosine receptors: Pharmacology, structure-activity relationships, and therapeutic potential. J Med Chem 1992, 35, 3, 407-22. |
| 【2】 Hong, O.; Jacobson, K.; Daly, J.; Shamim, M.; Padgett, W.; Ukena, D.; Non-xanthine heterocycles: Activity as antagonists of A1- and A2-adenosine receptors. Biochem Pharmacol 1988, 37, 4, 655-54. |
| 【3】 Peck, J.V.; Cusack, N.J.; N-0861. Drugs Fut 1993, 18, 5, 433. |
| 中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
|---|---|---|---|---|---|---|
| (I) | 15284 | 4,6-dichloro-5-nitropyrimidine | 4316-93-2 | C4HCl2N3O2 | 详情 | 详情 |
| (II) | 22845 | 5-Amino-4,6-dichloropyrimidine; 4,6-dichloro-5-pyrimidinylamine; 4,6-dichloro-5-pyrimidinamine | 5413-85-4 | C4H3Cl2N3 | 详情 | 详情 |
| (III) | 15285 | 6-chloro-N(4)-methyl-4,5-pyrimidinediamine; N-(5-amino-6-chloro-4-pyrimidinyl)-N-methylamine | C5H7ClN4 | 详情 | 详情 | |
| (IV) | 15286 | 6-chloro-9-methyl-9H-purine | 2346-74-9 | C6H5ClN4 | 详情 | 详情 |
| (V) | 63964 | (1R,2S,4S)bicyclo[2.2.1]hept-2-ylamine; (1R,2S,4S)bicyclo[2.2.1]heptan-2-amine | C7H13N | 详情 | 详情 |
Extended Information